These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 32948510)

  • 1. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
    Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cannabinoids on resting state functional brain connectivity: A systematic review.
    Lorenzetti V; Gaillard A; Thomson D; Englund A; Freeman TP
    Neurosci Biobehav Rev; 2023 Feb; 145():105014. PubMed ID: 36563921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the role of cannabinoids on osteoporosis: a review.
    Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK
    Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Action and Pharmacokinetics of Cannabis.
    Chayasirisobhon S
    Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of Δ
    Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
    Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
    Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
    Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
    Allendorfer JB; Szaflarski JP
    Epilepsy Behav; 2017 May; 70(Pt B):349-354. PubMed ID: 28109780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic Strategies for Rare Cannabinoids Derived from
    Nguyen GN; Jordan EN; Kayser O
    J Nat Prod; 2022 Jun; 85(6):1555-1568. PubMed ID: 35648593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure.
    Lambros AM; Sagar KA; Dahlgren MK; Kosereisoglu D; El-Abboud C; Smith RT; Gruber SA
    Sci Rep; 2023 Apr; 13(1):5869. PubMed ID: 37041309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in cannabis research from a pharmaceutical chemist's point of view].
    Müller CE
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):818-824. PubMed ID: 31161229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portable biosensors for rapid on-site determination of cannabinoids in cannabis, a review.
    Harpaz D; Bernstein N; Namdar D; Eltzov E
    Biotechnol Adv; 2022 Dec; 61():108031. PubMed ID: 36058440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical uses of cannabis and cannabinoids in the United States.
    Levinsohn EA; Hill KP
    J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
    Krebs MO; Kebir O; Jay TM
    Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis.
    Rodriguez CEB; Ouyang L; Kandasamy R
    Behav Pharmacol; 2022 Apr; 33(2&3):130-157. PubMed ID: 33709984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new Cannabis genome assembly associates elevated cannabidiol (CBD) with hemp introgressed into marijuana.
    Grassa CJ; Weiblen GD; Wenger JP; Dabney C; Poplawski SG; Timothy Motley S; Michael TP; Schwartz CJ
    New Phytol; 2021 May; 230(4):1665-1679. PubMed ID: 33521943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromolecular Mechanisms of Cannabis Action.
    Adel Y; Alexander SPH
    Adv Exp Med Biol; 2021; 1264():15-28. PubMed ID: 33332001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
    Weinstein A; Livny A; Weizman A
    Curr Pharm Des; 2016; 22(42):6366-6379. PubMed ID: 27549374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.